AU7260098A - Diagnosis and treatment of phosphatase 0r kinase-related disorders - Google Patents

Diagnosis and treatment of phosphatase 0r kinase-related disorders

Info

Publication number
AU7260098A
AU7260098A AU72600/98A AU7260098A AU7260098A AU 7260098 A AU7260098 A AU 7260098A AU 72600/98 A AU72600/98 A AU 72600/98A AU 7260098 A AU7260098 A AU 7260098A AU 7260098 A AU7260098 A AU 7260098A
Authority
AU
Australia
Prior art keywords
phosphatase
kinase
diagnosis
treatment
related disorders
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU72600/98A
Inventor
Harald App
Douglas Clary
Sara A. Courtneidge
Terance H. Hui
Bahija Jallal
Dave Markby
Susan Onrust
Elior Peles
Greg D. Plowman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sugen LLC
Original Assignee
Sugen LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sugen LLC filed Critical Sugen LLC
Publication of AU7260098A publication Critical patent/AU7260098A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Wood Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU72600/98A 1997-04-28 1998-04-27 Diagnosis and treatment of phosphatase 0r kinase-related disorders Abandoned AU7260098A (en)

Applications Claiming Priority (13)

Application Number Priority Date Filing Date Title
US4442897P 1997-04-28 1997-04-28
US60044428 1997-04-28
US4722297P 1997-05-20 1997-05-20
US60047222 1997-05-20
US4947797P 1997-06-11 1997-06-11
US4975697P 1997-06-11 1997-06-11
US60049756 1997-06-11
US60049477 1997-06-11
US4991497P 1997-06-18 1997-06-18
US60049914 1997-06-18
US6359597P 1997-10-23 1997-10-23
US60063595 1997-10-23
PCT/US1998/008439 WO1998049317A2 (en) 1997-04-28 1998-04-27 Diagnosis and treatment of phosphatase- 0r kinase-related disorders

Publications (1)

Publication Number Publication Date
AU7260098A true AU7260098A (en) 1998-11-24

Family

ID=27556472

Family Applications (1)

Application Number Title Priority Date Filing Date
AU72600/98A Abandoned AU7260098A (en) 1997-04-28 1998-04-27 Diagnosis and treatment of phosphatase 0r kinase-related disorders

Country Status (5)

Country Link
EP (1) EP0979288A2 (en)
JP (1) JP2002513289A (en)
AU (1) AU7260098A (en)
CA (1) CA2288221A1 (en)
WO (1) WO1998049317A2 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2220853A1 (en) * 1998-01-16 1999-07-16 Hsc Research And Development Limited Partnership Human lymphoid protein tyrosine phosphatases
AU3679400A (en) * 1999-04-16 2000-11-02 Kyowa Hakko Kogyo Co. Ltd. Novel tyrosine phosphatase
EP1046715A1 (en) * 1999-04-23 2000-10-25 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. Interaction of vascular-endothelial protein-tyrosine phosphatase with the angiopoietin receptor tie-2
AU2001232833A1 (en) * 2000-01-18 2001-07-31 Human Genome Sciences, Inc. Human protein tyrosine phosphatase polynucleotides, polypeptides, and antibodies
WO2002042435A2 (en) * 2000-11-27 2002-05-30 Bayer Aktiengesellschaft Regulation of human tyrosine phosphatase
ES2263862T3 (en) * 2003-03-07 2006-12-16 Istituto Nazionale Per Lo Studio E La Cura Dei Tumori ANAPLASIC LYMPHOMA KINASE TEST, ITS REAGENTS AND COMPOSITIONS.
EP3006039B1 (en) 2004-03-02 2021-01-06 Acceleron Pharma Inc. Alk7 polypeptides for use in promoting fat loss
WO2007037532A1 (en) * 2005-09-30 2007-04-05 Link Genomics, Inc. Therapeutic or diagnostic application of srms gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5294538A (en) * 1991-11-18 1994-03-15 Cold Spring Harbor Labs. Method of screening for antimitotic compounds using the CDC25 tyrosine phosphatase
AU683299B2 (en) * 1993-09-01 1997-11-06 Ludwig Institute For Cancer Research Nucleotide sequences for novel protein tyrosine phosphatases
US5830648A (en) * 1995-05-05 1998-11-03 Sugen, Inc. Assay and method for transcript imaging

Also Published As

Publication number Publication date
WO1998049317A3 (en) 1999-02-25
WO1998049317A2 (en) 1998-11-05
CA2288221A1 (en) 1998-11-05
JP2002513289A (en) 2002-05-08
EP0979288A2 (en) 2000-02-16

Similar Documents

Publication Publication Date Title
AU6974996A (en) Compositions for the treatment of dermatological disorders and methods for their use
AU6744798A (en) Health condition monitor and method of use
IL133800A0 (en) Imidazopyrimidines and imidazopyridines for the treatment of neurological disorders
AU2124397A (en) Compositions and methods for the treatment and diagnosis of cardiovascular disease
AU2209697A (en) Fluorocarbons for diagnosis and treatment of articular disorders
AU4054297A (en) Manipulations of nitrosative and oxidatives stress in the treatment of disease
HUP9902068A3 (en) Methods and compositions for the diagnosis and treatment of cancer
AU2749395A (en) Medical use of bromelain
AU9395998A (en) Compositions and methods for the treatment of immune related diseases
AU1578295A (en) Use of arylcyclobutylalkylamines for the treatment of seizures and neurological disorders
AU3760400A (en) Methods and reagents for the diagnosis and treatment of multiple sclerosis
AU2513997A (en) Diagnosis and monitoring of neurological disease
AU8479498A (en) Dual specificity phosphatase and methods of use
AU7260098A (en) Diagnosis and treatment of phosphatase 0r kinase-related disorders
HUP0000785A3 (en) Ointment for the treatment of burns and other skin diseases
AU6786898A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AUPN104895A0 (en) Methods of and preparations for the treatment of ailments and disorders
AU6786598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU2913397A (en) Method and system for non-invasive determination of the main cardiorespiratory parameters of the human body
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU6653698A (en) Use of the p-ten suppressor gene in diagnosis and treatment of cancer
AU1408999A (en) Detection and treatment of retinal degenerative disease
AU8580598A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU6786798A (en) Methods and compositions for the diagnosis and treatment of neuropsychiatric di sorders
AU4575897A (en) Pharmaceutical and diagnostic use of serum amyloid p component

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase